CoChat

Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase

Open access
Boyer, Paul L., Smith, Steven J., Zhao, Xue Zhi, Das, Kalyan, Gruber, Kevin, Arnold, Eddy, Burke, Terrence R., Hughes, Stephen H. · 2018 · Journal of Virology
Cited by 38

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

We tested three compounds for their ability to inhibit the RNase H (RH) and polymerase activities of HIV-1 reverse transcriptase (RT). A high-resolution crystal structure (2.2 Å) of one of the compounds showed that it chelates the two magnesium ions at the RH active site; this prevents the RH active site from interacting with, and cleaving, the RNA strand of an RNA-DNA heteroduplex. The compounds were tested using a variety of substrates: all three compounds inhibited the polymerase-independent RH activity of HIV-1 RT. Time-of-addition experiments showed that the compounds were more potent if they were bound to RT before the nucleic acid substrate was added. The compounds significantly inhibited the site-specific cleavage required to generate the polypurine tract (PPT) RNA primer that initiates the second strand of viral DNA synthesis. The compounds also reduced the polymerase activity of RT; this ability was a result of the compounds binding to the RH active site. These compounds appear to be relatively specific; they do not inhibit either Escherichia coli RNase HI or human RNase H2. The compounds inhibit the replication of an HIV-1-based vector in a one-round assay, and their potencies were only modestly decreased by mutations that confer resistance to integrase strand transfer inhibitors (INSTIs), nucleoside analogs, or nonnucleoside RT inhibitors (NNRTIs), suggesting that their ability to block HIV replication is related to their ability to block RH cleavage. These compounds appear to be useful leads that can be used to develop more potent and specific compounds. IMPORTANCE Despite advances in HIV-1 treatment, drug resistance is still a problem. Of the four enzymatic activities found in HIV-1 proteins (protease, RT polymerase, RT RNase H, and integrase), only RNase H has no approved therapeutics directed against it. This new target could be used to design and develop new classes of inhibitors that would suppress the replication of the drug-resistant variants that have been selected by the current therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.02203-17

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 32

  1. 10.1016/j.jmb.2009.03.025 · DOI · Paper page
  2. 10.1021/jm900597q · DOI · Paper page
  3. 10.1074/jbc.M114.569707 · DOI · Paper page
  4. 10.1021/acs.jmedchem.7b00440 · DOI · Paper page
  5. 10.3389/fmicb.2017.00440 · DOI
  6. 10.1128/microbiolspec.MDNA3-0027-2014 · DOI · Paper page
  7. 10.1021/jm5001908 · DOI
  8. 10.1021/jm040840e · DOI · Paper page
  9. 10.1073/pnas.0711209105 · DOI · Paper page
  10. 10.1128/JVI.00353-10 · DOI · Paper page
  11. 10.1074/jbc.M507839200 · DOI
  12. 10.1074/jbc.M201645200 · DOI · Paper page
  13. 10.1128/JVI.78.12.6112-6121.2004 · DOI
  14. 10.1016/j.jmb.2004.09.081 · DOI
  15. 10.1111/j.1742-4658.2009.06908.x · DOI · Paper page
  16. 10.1128/JVI.75.2.672-686.2001 · DOI
  17. 10.1074/jbc.M700043200 · DOI
  18. 10.1074/jbc.M116.753160 · DOI
  19. 10.1016/j.str.2009.09.016 · DOI · Paper page
  20. 10.1016/j.jmb.2014.05.006 · DOI · Paper page
  21. 10.1021/jm070715d · DOI
  22. 10.1016/j.bmcl.2010.08.135 · DOI
  23. 10.1021/jm00395a015 · doi:10.1021/jm00395a015
  24. 10.1128/JVI.02611-06 · DOI
  25. 10.3791/51400 · DOI
  26. 10.1021/jm401902n · DOI
  27. 10.1021/acschembio.5b00948 · DOI · Paper page
  28. 10.1097/QAI.0000000000001031 · DOI · Paper page
  29. 10.1093/nar/gkn464 · DOI · Paper page
  30. 10.1107/S0907444910048675 · DOI · Paper page
  31. 10.1107/S0907444909052925 · DOI · Paper page
  32. 10.1107/S0907444904019158 · DOI · Paper page

Cited by

See all 38

Metadata

Authors
Boyer, P. L., Smith, S. J., Zhao, X. Z., Das, K., Gruber, K., Arnold, E., Burke, T. R., & Hughes, S. H.
Venue
Journal of Virology
Published
2018-07
Volume
92
Issue
13
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2808340159
Cited by
38
References
5
FWCI
4.15
Type
journal article
Language
en
Open access
bronze
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. https://app.cochat.ai/papers/10.1128/jvi.02203-17
The paper
Boyer, P. L., Smith, S. J., Zhao, X. Z., Das, K., Gruber, K., Arnold, E., Burke, T. R., & Hughes, S. H. (2018). Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. Journal of Virology. https://doi.org/10.1128/jvi.02203-17

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.